冠状动脉支架植入术后不停用双联抗血小板药物植入心血管植入型电子器械  

Continue using dual-antiplatelet drugs after coronary stenting during implantation of cardiovascular implantable electronic device

作　　者：姜东炬[1] 胡高频[1] 付荣[1] 贾玉琳[1] 王冬冬[1] 陶爱萍[1] 

机构地区：[1]解放军第210医院心内科沈阳军区大连心血管内科疾病诊疗中心,大连116021

出　　处：《中华心律失常学杂志》2014年第1期49-51,共3页Chinese Journal of Cardiac Arrhythmias

摘　　要：目的 观察冠状动脉（冠脉）支架植入术后在不停用双联抗血小板药物情况下心血管植入型电子器械（CIED）术后并发症发生情况.方法 将2008年3月至2013年3月在大连解放军第210医院心内科接受CIED植入的64例患者分为2组,双联抗血小板药物组32例,植入冠脉药物洗脱支架术后1年内持续使用双联抗血小板药物（阿司匹林100 mg＋氯吡格雷75 mg,每日1次口服）期间符合CIED适应证,在不停用的情况下植入CIED;对照组32例,采用随机数法抽取同期未使用或停用抗血小板药物情况下植入CIED患者.观察终点：术后30 d内囊袋血肿发生率.结果 2组患者术后30 d内均无囊袋血肿发生.结论 冠脉支架植入术后在不停用双联抗血小板药物情况下植入CIED未见囊袋血肿发病率增加,但需增加病例数、延长随访期进一步观察.Objective To observe the skin-pocket hematoma complication in using dual-antiplatelet drugs after coronary stenting during implantation of cardiovascular implantable electronic device （CIED）.Methods This was single-center retrospective study of 32 patients with continue using dualantiplatelet drugs（aspirin,10 mg/d and clopidogrel,75mg/d,Qd） after coronary stenting and another 32 patients with no antiplatelet drugs during implantation of CIED as control.The skin-pocket hematoma complication during 30 days follow-up after operation was compared between two groups.Results There was no statistic difference in skin-pocket hematoma complication during 30 days follow-up after operation between two groups（0% vs.0%,P〉0.05）.Conclusion It maybe safety for the patients with coronary stenting continue using dual-antiplatelet drugs during implantation of CIED and don＆#39;t increase the skin-pocket hematoma complication.

关 键 词：支架 抗血小板药物 心血管植入型电子器械 并发症 

分 类 号：R541.4[医药卫生—心血管疾病]